Patents by Inventor Anders Olofsson

Anders Olofsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5659284
    Abstract: An electric protective circuit includes an electric fuse and an electric resistance loop connected in series with the fuse, the fuse and loop being mounted on a substrate. The fuse includes a solder that is connected as a resistance in a current series circuit between connection terminals and that melts at elevated temperatures caused by heating of the substrate. The solder is surrounded by a material that protects the solder against oxidation by the surrounding air and completely covers the solder, enabling the solder to contract onto the connecting terminals when it melts and break the current path. The material is temperature-stable in a solid state of normal fuse operating temperatures and includes one or a combination of waxes, resins, thermoplastics, and synthetic fluxes. The material is applied in a region or area surrounding the solder that is delimited by barrier walls that prevent the material from running away from the region.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: August 19, 1997
    Assignee: Telefonaktiebolaget LM Ericsson
    Inventor: Lars-Anders Olofsson
  • Patent number: 5346993
    Abstract: The invention relates to large latent complexes of TGF-.beta.2 and TGF-.beta.3, and methods for isolating these. The complex consists of a dimerized form of TGF-.beta.2 or TGF-.beta.3, the appropriate latency associated peptide, and the latent TGF-.beta.1 binding protein, referred to as LTBP. Also described is a protein which binds to all of TGF-.beta.1, TGF-.beta.2 and TGF-.beta.3, but is immunologically distinct from LTBP, referred to as LTBP-2.
    Type: Grant
    Filed: July 15, 1993
    Date of Patent: September 13, 1994
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Kohei Miyazono, Carl-Henrik Heldin, Anders Olofsson
  • Patent number: 5280109
    Abstract: The invention relates to large latent complexes of TGF-.beta.2 and TGF-.beta.3, and methods for Isolating these. The complex consists of a dimerized form of TGF-.beta.2 or TGF-.beta.3, the appropriate latency associated peptide, and the latent TGF-.beta.1 binding protein, referred to as LTBP. Also described is a protein which binds to all of TGF-.beta.1, TGF-.beta.2 and TGF-.beta.3, but is immunologically distinct from LTBP, referred to as LTBP-2.
    Type: Grant
    Filed: January 27, 1992
    Date of Patent: January 18, 1994
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Kohei Miyazono, Carl-Henrik Heldin, Anders Olofsson
  • Patent number: 5236024
    Abstract: A counter blade is disclosed for use in a chipping machine which comprises a chipper disc rotatably mounted in the chipper frame by means of a shaft supporting the disc. The counter blade is attached to the chipper frame essentially at the intersection of a blade mounted in the chipper disc and the log to be chipped, in such manner that, on the side opposite to the chipping blade, the counter blade rests against the log to be chipped. The counter blade consists of a first and a second blade part placed at an obtuse angle relative to each other. According to the present invention, the counter blade consists of two essentially elongated elements having an arris forming the cutting edge of the counter blade at least on one of its longitudinal sides. The end faces of the counter blade elements are so formed as to permit connection to an adjacent counter blade element so that two counter blades form a continuous cutting edge of the counter blade.
    Type: Grant
    Filed: May 5, 1992
    Date of Patent: August 17, 1993
    Assignee: Kone Oy
    Inventors: Ake Svensson, Anders Olofsson, Ari Hannimaki, Pekka Kokko
  • Patent number: 5177197
    Abstract: Purified protein known as platelet TGF-.beta.1-BP (transforming growth factor-.beta.1-binding protein) is described. The protein is useful for purposes such as the production of antisera which are useful in identifying complexes containing the binding protein, as well as in formation of labeled probes. Also described are purified DNA which expresses the protein, as well as messenger RNA translated into the protein. The protein contains 16 epidermal growth factors (EGF) like repeats, and 3 repeats not found in other proteins. The DNA for the protein is found to contain consensus sequences for hydroxylation of asparagine/aspartic acid residues, and, in the purified protein beta hydroxylated asparagine residues were found.
    Type: Grant
    Filed: February 27, 1990
    Date of Patent: January 5, 1993
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Tetsuto Kanzaki, Anders Olofsson, Anita Moren, Christer Wernstedt, Ulf Hellman, Kohei Miyazono, Lena Claesson-Welsh, Carl-Henrik Heldin